Koers Kamada Ltd. TEL AVIV STOCK EXCHANGE
Aandelen
KMDA
IL0010941198
Farmaceutische producten
Omzet 2024 * | 573 mln. 151 mln. 141 mln. | Omzet 2025 * | 706 mln. 185 mln. 173 mln. | Marktkapitalisatie | 1,11 mld. 293 mln. 274 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 46 mln. 12,08 mln. 11,3 mln. | Nettowinst (verlies) 2025 * | 84 mln. 22,06 mln. 20,64 mln. | EV/omzet 2024 * | 1,94 x |
Nettoliquiditeiten 2024 * | - 0 0 | Nettoliquiditeiten 2025 * | - 0 0 | EV/omzet 2025 * | 1,58 x |
K/w-verhouding 2024 * |
-
| K/w-verhouding 2025 * |
-
| Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 54,25% |
Recentste transcriptie over Kamada Ltd.
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Amir London
CEO | Chief Executive Officer | 55 | 09-12-13 |
David Tsur
FOU | Founder | 73 | 13-12-90 |
Chaime Orlev
DFI | Director of Finance/CFO | 53 | 31-12-17 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Ishay Davidi
BRD | Director/Board Member | 62 | 24-12-19 |
Leon Recanati
BRD | Director/Board Member | 76 | 01-05-05 |
David Tsur
FOU | Founder | 73 | 13-12-90 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-4,66% | 86,13 mld. | |
+1,32% | 39,82 mld. | |
-19,27% | 30,42 mld. | |
+57,86% | 25,23 mld. | |
-16,09% | 15,35 mld. | |
-9,14% | 11,95 mld. | |
-17,69% | 11,6 mld. | |
-43,00% | 11,51 mld. | |
+5,24% | 8,71 mld. |